Gross Margin
11.55%vs Specialty Chemicals peers Updated Aug 20, 2026Profit Margin
-5.09%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Margin
-5.49%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Assets (TTM)
-2.04%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Equity (TTM)
-11.27%vs Specialty Chemicals peers Updated Aug 20, 2026Revenue (TTM)
2.93BCNY435.86M · vs all stocks (USD) Updated Aug 20, 2026Revenue per Share (TTM)
15.11CNYUpdated Aug 20, 2026Quarterly Revenue Growth
48.90%vs Specialty Chemicals peers Updated Aug 20, 2026Gross Profit (TTM)
324.39MCNY48.18M · vs all stocks (USD) Updated Aug 20, 2026EBITDA (TTM)
205.79MCNY30.56M · vs all stocks (USD) Updated Aug 20, 2026Net Income (TTM)
-149.36MCNY-22.18M · vs all stocks (USD) Updated Aug 20, 2026Quarterly Earnings Growth (YoY)
24.76%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Cash Flow (TTM)
114.86MCNY17.06M · vs all stocks (USD) Updated Aug 20, 2026Levered Free Cash Flow (TTM)
-864.51MCNY-128.40M · vs all stocks (USD) Updated Aug 20, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Aug 20, 2026Minority Interest (Equity)
113.16MCNYFY2025 · Dec 31, 2025Revenue
2.69BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.33BCNYFY2025 · Dec 31, 2025Gross Profit
354.36MCNYFY2025 · Dec 31, 2025Operating Income
-82.38MCNY-12.24M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-137.72MCNYFY2025 · Dec 31, 2025Income Tax Expense
-24.84MCNYFY2025 · Dec 31, 2025Net Income
-112.88MCNYFY2025 · Dec 31, 2025EBIT
-63.02MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
205.79MCNYFY2025 · Dec 31, 2025Research & Development
70.41MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
126.85MCNYFY2025 · Dec 31, 2025Other Operating Expenses
28.69MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.06MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
74.70MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.3927CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.3927CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
192.79MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
192.79MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-112.88MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
37.17MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-1.16BCNYFY2025 · Dec 31, 2025Free Cash Flow
-2.09BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
256.71MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-112.88MCNYFY2025 · Dec 31, 2025Other Non-cash Items
106.94MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-886.17MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-266.71MCNYFY2025 · Dec 31, 2025Capital Expenditures
-933.47MCNYFY2025 · Dec 31, 2025Net Acquisitions
-11.20MCNYFY2025 · Dec 31, 2025Purchase of Investments
-321.43KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-944.99MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.06BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-365.32MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-37.97MCNYFY2025 · Dec 31, 2025Other Financing Charges
80.92MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
737.31MCNYFY2025 · Dec 31, 2025